Back to Authors

Mangaonkar, Abhishek A.

https://orcid.org/0000-0003-2458-9887

A5012298768 | I1330342723

Mayo Clinic

Citations 247

Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9735-9736

10.1182/blood-2022-163450

Prevalence and Impact of Clonal Hematopoiesis in Therapy Related Myeloid Neoplasms Occurring in the Context of Low-Grade Follicular Lymphoma Treated with Radioisotope Therapy

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11403-11405

10.1182/blood-2022-165124

U2AF1 Mutant Clonal Hematopoiesis Is Infrequent, Context Dependent, and Commonly Co-Occurs with BCOR Mutations

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11408-11409

10.1182/blood-2022-166794

DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11410-11411

10.1182/blood-2022-167359

Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6962-6963

10.1182/blood-2022-167978

Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6964-6965

10.1182/blood-2022-168349

Longitudinal Single Cell Multiomic Analysis of a Patient with GATA2 Haploinsufficiency with ASXL1 Mutant Clonal Hematopoiesis

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8672-8673

10.1182/blood-2022-167808

Clinical and Molecular Characteristics of ETV6 Mutated Myeloid Malignancies

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6912-6914

10.1182/blood-2022-170641

CPX-351 for Blast-Phase Myeloproliferative Neoplasm (MPN-BP): Mayo Clinic Experience in 10 Consecutive Patients

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9704-9705

10.1182/blood-2022-160222

Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients

American Journal of Hematology | November 20, 2022 | Volume: 98 | Issue: 2 | Pages: No page available

10.1002/ajh.26786 | PMID 36403135